糖尿病患者-话题@MedSci

#糖尿病患者#

1747篇内容 | 8280人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1475176, encodeId=2e5114e51762e, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=AHA 2021：长期、低剂量阿司匹林不影响2型糖尿病患者的痴呆风险, objectType=article, longId=220528, objectId=26ab220528a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26ab220528a6, replyNumber=0, likeNumber=85, createdTime=2021-11-19, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26ab220528a6, moduleTitle=AHA 2021：长期、低剂量阿司匹林不影响2型糖尿病患者的痴呆风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26ab220528a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475175, encodeId=44ea14e5175dd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Front Oncol：血糖控制对晚期非小细胞肺癌(NSCLC)伴有糖尿病患者的生存影响, objectType=article, longId=220501, objectId=7da92205016e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da92205016e, replyNumber=0, likeNumber=66, createdTime=2021-11-18, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da92205016e, moduleTitle=Front Oncol：血糖控制对晚期非小细胞肺癌(NSCLC)伴有糖尿病患者的生存影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da92205016e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475174, encodeId=bcf414e51747c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险, objectType=article, longId=220478, objectId=821b2204e80a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=821b2204e80a, replyNumber=0, likeNumber=95, createdTime=2021-11-18, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=821b2204e80a, moduleTitle=Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=821b2204e80a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475173, encodeId=2f0e14e5173dd, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：较高的非严重低血糖发生率与2型糖尿病患者随后发生严重低血糖和主要心血管不良事件的风险增加相关, objectType=article, longId=220443, objectId=d1ee220443f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1ee220443f2, replyNumber=0, likeNumber=60, createdTime=2021-11-17, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1ee220443f2, moduleTitle=Diabetologia：较高的非严重低血糖发生率与2型糖尿病患者随后发生严重低血糖和主要心血管不良事件的风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1ee220443f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475172, encodeId=7f6f14e5172fa, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：心肌梗死后的心肌瘢痕对糖尿病患者左心室变形的影响, objectType=article, longId=220363, objectId=fa4e22036329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa4e22036329, replyNumber=0, likeNumber=94, createdTime=2021-11-16, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa4e22036329, moduleTitle=Cardiovasc Diabetol：心肌梗死后的心肌瘢痕对糖尿病患者左心室变形的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa4e22036329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475171, encodeId=62d314e5171c5, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：患者电子数据的警示管理系统有利于2型糖尿病患者的降脂治疗, objectType=article, longId=220272, objectId=9a9a2202e288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a9a2202e288, replyNumber=0, likeNumber=123, createdTime=2021-11-15, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a9a2202e288, moduleTitle=Diabetologia：患者电子数据的警示管理系统有利于2型糖尿病患者的降脂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a9a2202e288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475170, encodeId=35b514e5170c6, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制, objectType=article, longId=220270, objectId=1e7d2202e0c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7d2202e0c3, replyNumber=0, likeNumber=22, createdTime=2021-11-15, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7d2202e0c3, moduleTitle=Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7d2202e0c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475169, encodeId=cdbb14e51693f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：年轻2型糖尿病患者的发病居然另有他因？, objectType=article, longId=220226, objectId=efb8220226f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efb8220226f9, replyNumber=0, likeNumber=101, createdTime=2021-11-13, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efb8220226f9, moduleTitle=Diabetologia：年轻2型糖尿病患者的发病居然另有他因？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efb8220226f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475166, encodeId=4fa514e5166a4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=BMJ子刊：年轻糖尿病患者“糖尿病视网膜病变”筛查是否被忽视？看看英国这篇研究怎么说！, objectType=article, longId=220154, objectId=b8c82201542d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8c82201542d, replyNumber=0, likeNumber=81, createdTime=2021-11-13, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8c82201542d, moduleTitle=BMJ子刊：年轻糖尿病患者“糖尿病视网膜病变”筛查是否被忽视？看看英国这篇研究怎么说！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8c82201542d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475168, encodeId=cc2f14e5168f9, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：1型糖尿病患者下肢截肢的危险因素和随时间变化的发病率, objectType=article, longId=220125, objectId=e5d322012599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5d322012599, replyNumber=0, likeNumber=98, createdTime=2021-11-12, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5d322012599, moduleTitle=Diabetologia：1型糖尿病患者下肢截肢的危险因素和随时间变化的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5d322012599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475167, encodeId=59ac14e51678b, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab:口服沙格列汀治疗日本2型糖尿病患者的疗效和安全性, objectType=article, longId=220124, objectId=2ab322012418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ab322012418, replyNumber=0, likeNumber=86, createdTime=2021-11-12, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ab322012418, moduleTitle=Diabetes Obes Metab:口服沙格列汀治疗日本2型糖尿病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ab322012418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475165, encodeId=c00714e516572, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Eur Heart：肥胖和达格列净对2型糖尿病患者心血管和肾脏结局的影响, objectType=article, longId=220050, objectId=2cb022005032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cb022005032, replyNumber=0, likeNumber=70, createdTime=2021-11-11, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cb022005032, moduleTitle=Eur Heart：肥胖和达格列净对2型糖尿病患者心血管和肾脏结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cb022005032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475164, encodeId=aed114e5164a4, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：每日三次的基础胰岛素治疗中加入短效艾塞那肽对1型糖尿病患者骨代谢的影响, objectType=article, longId=220047, objectId=feb722004e41, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feb722004e41, replyNumber=0, likeNumber=119, createdTime=2021-11-11, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feb722004e41, moduleTitle=Diabetes Obes Metab：每日三次的基础胰岛素治疗中加入短效艾塞那肽对1型糖尿病患者骨代谢的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feb722004e41)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475163, encodeId=9cfc14e51639d, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：表现为非蛋白尿的肾功能不全的2型糖尿病患者的肾脏结局和全因死亡率, objectType=article, longId=220042, objectId=1d0c22004283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0c22004283, replyNumber=0, likeNumber=47, createdTime=2021-11-11, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0c22004283, moduleTitle=Diabetologia：表现为非蛋白尿的肾功能不全的2型糖尿病患者的肾脏结局和全因死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0c22004283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475162, encodeId=bbcc14e516236, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Lancet Diabetes Endocrinol：应用GLP-1受体激动剂治疗2型糖尿病患者的心血管、死亡率和肾脏结局——随机试验的系统回顾和荟萃分析, objectType=article, longId=220003, objectId=76552200039d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76552200039d, replyNumber=0, likeNumber=15, createdTime=2021-11-10, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76552200039d, moduleTitle=Lancet Diabetes Endocrinol：应用GLP-1受体激动剂治疗2型糖尿病患者的心血管、死亡率和肾脏结局——随机试验的系统回顾和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76552200039d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475299, encodeId=bab814e52996c, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系, objectType=article, longId=219959, objectId=3e8421995953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e8421995953, replyNumber=0, likeNumber=108, createdTime=2021-11-09, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e8421995953, moduleTitle=Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e8421995953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475298, encodeId=48ba14e5298f8, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：二肽基肽酶-4抑制剂利格列汀与磺脲类格列美脲在成人2型糖尿病患者餐后肾血流动力学影响, objectType=article, longId=219911, objectId=452e2199110c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=452e2199110c, replyNumber=0, likeNumber=28, createdTime=2021-11-08, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=452e2199110c, moduleTitle=Diabetes Obes Metab：二肽基肽酶-4抑制剂利格列汀与磺脲类格列美脲在成人2型糖尿病患者餐后肾血流动力学影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=452e2199110c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475161, encodeId=52f714e516132, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：短期使用达格列净对1型糖尿病患者低血糖意识损害的影响, objectType=article, longId=219867, objectId=fa7521986ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa7521986ebe, replyNumber=0, likeNumber=99, createdTime=2021-11-07, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa7521986ebe, moduleTitle=Diabetes Obes Metab：短期使用达格列净对1型糖尿病患者低血糖意识损害的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa7521986ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475160, encodeId=106514e5160df, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响, objectType=article, longId=219865, objectId=809721986557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=809721986557, replyNumber=0, likeNumber=77, createdTime=2021-11-07, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=809721986557, moduleTitle=DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=809721986557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1475159, encodeId=835a14e5159a3, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, objectTitle=Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能, objectType=article, longId=219741, objectId=84c2219e41fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84c2219e41fe, replyNumber=0, likeNumber=67, createdTime=2021-11-05, rootId=0, userName=xue8604, userId=a38f7243741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84c2219e41fe, moduleTitle=Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84c2219e41fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

糖尿病患者

2020-05-29

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

AHA 2021：长期、低剂量阿司匹林不影响2型糖尿病患者的痴呆风险

2021-11-19

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Front Oncol：血糖控制对晚期非小细胞肺癌(NSCLC)伴有糖尿病患者的生存影响

2021-11-18

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Circulation：Finerenone降低慢性肾病和2型糖尿病患者心衰风险

2021-11-18

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：较高的非严重低血糖发生率与2型糖尿病患者随后发生严重低血糖和主要心血管不良事件的风险增加相关

2021-11-17

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Cardiovasc Diabetol：心肌梗死后的心肌瘢痕对糖尿病患者左心室变形的影响

2021-11-16

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：患者电子数据的警示管理系统有利于2型糖尿病患者的降脂治疗

2021-11-15

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab：利拉鲁肽与口服降糖药作为附加疗法在单独使用二甲双胍的2型糖尿病患者中维持血糖控制

2021-11-15

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：年轻2型糖尿病患者的发病居然另有他因？

2021-11-13

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

BMJ子刊：年轻糖尿病患者“糖尿病视网膜病变”筛查是否被忽视？看看英国这篇研究怎么说！

2021-11-13

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：1型糖尿病患者下肢截肢的危险因素和随时间变化的发病率

2021-11-12

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab:口服沙格列汀治疗日本2型糖尿病患者的疗效和安全性

2021-11-12

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Eur Heart：肥胖和达格列净对2型糖尿病患者心血管和肾脏结局的影响

2021-11-11

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab：每日三次的基础胰岛素治疗中加入短效艾塞那肽对1型糖尿病患者骨代谢的影响

2021-11-11

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：表现为非蛋白尿的肾功能不全的2型糖尿病患者的肾脏结局和全因死亡率

2021-11-11

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Lancet Diabetes Endocrinol：应用GLP-1受体激动剂治疗2型糖尿病患者的心血管、死亡率和肾脏结局——随机试验的系统回顾和荟萃分析

2021-11-10

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetologia：糖尿病患者降糖药物使用与新发房颤的关系

2021-11-09

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab：二肽基肽酶-4抑制剂利格列汀与磺脲类格列美脲在成人2型糖尿病患者餐后肾血流动力学影响

2021-11-08

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes Obes Metab：短期使用达格列净对1型糖尿病患者低血糖意识损害的影响

2021-11-07

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响

2021-11-07

xue8604 (审核中...)

前往app查看评论内容

#糖尿病患者#

Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能

2021-11-05

科室
- - 订阅+
  - 更多科室
工具
服务